Another cost of generic Prilosec

Executive Summary

Andrx notes in Nov. 15 10-Q filing that scale-up for the expected launches of generic omeprazole and bupropion has affected production of commercial products. "Through much of 2002, besides the currently marketed products, the company was concurrently working toward building launch quantities for two significant potential product candidates, bioequivalent versions of Prilosec and Wellbutrin SR/Zyban, which resulted in inefficiencies, equipment failures and rejection lots, and at times interrupted the company's ability to fully meet the actual demand for certain of its products," Andrx said. Generic Prilosec launch supplies will not be used after a federal court ruled that Andrx infringed AstraZeneca's patents...